For CML, the science is here now access must follow
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
For CML, the science is here now access must follow
-
Narrated by:
-
By:
About this listen
Jerald Radich, MD, of Fred Hutchinson Cancer Center in Seattle, sits down with Saad Usmani, MD, of Memorial Sloan Kettering Cancer Center in New York, to reflect on progress made in chronic myeloid leukemia (CML) and the work still ahead to ensure equitable care worldwide.
“The issue with CML is that most of the CML in the world is in developing countries, and they can’t afford a drug, they can’t afford testing,” Dr. Radich said on the podcast.
The pair also discussed current funding cuts. “As a culture and a government, we’ve lost our imagination,” Dr. Radich said, adding that giving up the edge provided by our institutions for basic discovery “is not smart.”
No reviews yet